Szarkóma: vizsgálatok itt: Dánia

In Dánia 20 Also abroad 605

20 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.

2. fázisTaking people
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Where
Aarhus N, Copenhagen, Odense
Életkor
18 év and over
People
111 worldwide
Run by
Bayer
See details and how to joinNCT06760819 · EU 2024-517419-62-00
1/2. fázisTaking people
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Where
Copenhagen Oe
Életkor
6 hónap to 25 év
People
90 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00
3. fázisTaking people
Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
Where
Aarhus, Copenhagen, Herlev
Életkor
4 év and over
People
530 worldwide
Run by
Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07871864
1. fázisTaking people
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Where
Odense C
Életkor
18 év and over
People
180 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07261631
3. fázisTaking people
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Where
Aarhus, Herlev
Életkor
18 év and over
People
250 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04031677
2. fázisNot yet taking people in Dánia
Paediatric Sarcoma, Hybrid Imaging & FAPI - Raising the Diagnostic Standard for Paediatric Sarcoma Patients, Combining Novel Radiotracer FAPI and Whole-body PET/MRI
Where
Copenhagen Oe
Életkor
Up to 17 év
People
40
Run by
Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT07861217 · EU 2025-524874-41-00
1. fázisTaking people
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
Where
København Ø
Életkor
18 év and over
People
405 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT06884618 · EU 2024-519622-20-00
1/2. fázisTaking people
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Where
Copenhagen Oe
Életkor
Up to 25 év
People
75 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT04094610 · EU 2023-506464-14-00
1. fázisTaking people
A phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-DFC413 and safety and imaging properties of [68Ga]Ga-NNS309 in patients with solid tumors
Where
Copenhagen Oe, Odense C
Életkor
18 év and over
People
62 worldwide
Run by
Novartis Pharma AG
See details and how to join2025-521702-18-00 · EU 2025-521702-18-00
1. fázisTaking people
Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors
Where
Odense C
Életkor
18 év and over
People
66 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07630961
No phaseNot yet taking people in Dánia
Sarcoma and Intra-infusion Exercise for Better Outcomes
Where
Herlev
Életkor
18 év and over
People
16
Run by
Kira Bloomquist
See details and how to joinNCT07785882
No phaseTaking people
Fluorescence-Guided Optimization of Sarcoma Margins
Where
Aarhus N, Copenhagen
Életkor
18 év and over
People
90
Run by
University of Aarhus
See details and how to joinNCT07134192
1/2. fázisTaking people
Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administered in Adult Patients With Metastatic or Locally Advanced PDAC
Where
Copenhagen
Életkor
18 év and over
People
96 worldwide
Run by
Anocca AB
See details and how to joinNCT07145450
1/2. fázisTaking people
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Where
Copenhagen Oe
Életkor
12 év and over
People
500 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00
No phaseTaking people
The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)
Where
Aarhus
Életkor
18 év and over
People
100 worldwide
Run by
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
See details and how to joinNCT06408441
No phaseTaking people
Evaluating Health Literacy, Expectations and Regrets in Patients Undergoing Major Abdominal Surgery for Malignant Disease
Where
Copenhagen
Életkor
18 év and over
People
90
Run by
Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT07450950
2/3. fázisTaking people
rEECur: International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma
Where
Aarhus N, Copenhagen Oe, Herlev
People
436 worldwide
Run by
The University Of Birmingham
See details and how to join2024-516078-31-00 · EU 2024-516078-31-00
1/2. fázisTaking people
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
Where
Aarhus N, Copenhagen Oe, Herlev
People
1672 worldwide
Run by
University of Birmingham
See details and how to joinNCT04625907 · EU 2024-510579-40-00
2. fázisTaking people
Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients
Where
Aarhus N, Herlev
Életkor
18 év and over
People
80 worldwide
Run by
Niels Junker
See details and how to joinNCT05961761 · EU 2024-513727-16-00
No phaseTaking people
Investigating Cognitive Impairment in Young Patients With Cancer Prospectively
Where
Copenhagen
Életkor
7 év to 29 év
People
100
Run by
Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT05840575